This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slipped 2.95% to $2.63 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.99% to 3,998.95 and the Dow Jones Industrial Average DJIA rising 0.51% to 32,036.90. Ocugen Inc. closed $15.02 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. ADVM fell 1.15% to $1.72, Ocular Therapeutix Inc. OCUL fell 1.95% to $4.52, and Kodiak Sciences Inc. KOD fell 0.40% to $9.90. Trading volume (3.8 M) remained 3.1 million below its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2022.
(END) Dow Jones Newswires
July 21, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.